USANA Health Sciences USNA North Asia — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's north asia — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's north asia — net sales?
- USANA Health Sciences (USNA) reported north asia — net sales of $15.35M in Q1 2026.
- How has USANA Health Sciences's north asia — net sales changed year-over-year?
- USANA Health Sciences's north asia — net sales decreased by 18.9% year-over-year, from $18.94M to $15.35M.
- What is the long-term trend for USANA Health Sciences's north asia — net sales?
- Over 4 years (2021 to 2025), USANA Health Sciences's north asia — net sales has grown at a -14.1% compound annual growth rate (CAGR), from $129.92M to $70.63M.
- What does north asia — net sales mean?
- This metric represents the total revenue generated from the sale of nutritional and personal-care products within the North Asia geographic segment. It reflects the company's market penetration and consumer demand for its direct-selling business model in this specific region. Monitoring this figure helps investors assess regional growth trends and the effectiveness of local sales strategies.